Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on September 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

LIDOCAINE HYDROCHLORID

Closed
SPE2DP-26-T-4823Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 17 days
NAICS: 325412
New
Federal
6505--FY27 Lenalidomide BPA
Solicitation # 36C26227Q0083
The Department of Veterans Affairs, through Network Contracting Office 22, has issued this Sources Sought Notice and Request for Information to identify qualified sources for a Health Service Area 5.3 Blanket Purchase Agreement. The government seeks providers capable of supplying Lenalidomide medication in multiple dosage strengths, specifically 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg oral capsules. The medication will be delivered to eight participating VA Medical Centers across Arizona, California, and New Mexico. Due to the nature of the medication, the contractor must hold Food and Drug Administration Risk Evaluation and Mitigation Strategy certification to dispense the product and must ensure strict adherence to handling, storage, and temperature control regulations to maintain medication integrity. This is not a formal solicitation, and responses are intended for market research and planning purposes to inform future acquisition decisions. The anticipated period of performance is one year from the date of award, with orders placed on an as-needed basis via approved purchase orders. Interested respondents must provide a comprehensive capabilities statement, business size status relative to NAICS 325412, and details regarding their status as a manufacturer or authorized distributor. Submissions must also address compliance with the Buy American Act, the Non-Manufacturer Rule, and limitations on subcontracting. All responses must be submitted via email to the designated contracting officer by November 12, 2026.
262-NETWORK Contract Office 22 (36C262)

POSTED

1 day ago

DEADLINE

in 12 days

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-4823 is a request for quotations issued by DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Lidocaine Hydrochloride and Dextrose Injection (NSN 6505-01-194-7265). The requirement is for one package containing 18 units, with a delivery lead time of 20 days and an original required delivery date of September 3, 2026. The product is FDA-regulated and has a non-extendable shelf life of 18 months, requiring at least 16 months of remaining shelf life upon delivery to the first government activity. Delivery is FOB destination to the USS Somerset LPD 25. The contract mandates strict adherence to DLA packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers, with palletization following RP001 requirements. Non-hazardous materials must comply with ASTM D3951, while hazardous materials must follow TQ requirement IP025 and FED-STD-313. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American Act and Berry Amendment. Quotations were due by September 8, 2026.

General Info

Procurement of Lidocaine and Dextrose injections for USS Somerset by September 3, 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

UNIT 100232 BOX 1, FPO, AP, 96678, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts

Full Description

Show more
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJ
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
500ML,18'S
.
UNIT OF ISSUE: PACKAGE OF 18S
.
*SHORTAGE
BAXTER & HOSPIRA HAVE LIDOCAINE PREMIXED INJECTION ON SHORTAGE DUE TO
MANUFACTURING DELAYS AND INCREASED DEMAND
.
BAXTER HAS LIMITED SUPPLIES OF 0.4% LIDOCAINE AND 5% DEXTROSE,500 ML
PREMIXED BAGS AND
0.8% LIDOCAINE AND 5% DEXTROSE, 250 ML PREMIXED BAGS.
1 PG = 18 EA
SHELF LIFE IS 18 MONTHS. AT LEAST 16 MONTHS OF
SHELF LIFE SHALL REMAIN AT THE TIME OF DELIVERY
TO THE FIRST GOVERNMENT ACTIVITY
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
SPE2DP-26-T-4823
SECTION B
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
BAXTER HEALTHCARE CORP IV 04687 P/N 2B0973P BAXTER HEALTHCARE CORP IV 04687 P/N NDC00338-0409-03
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018127534 0001 PG 1.000
NSN/MATERIAL:6505011947265
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R23181
USS SOMERSET LPD 25
UNIT 100232 BOX 1
FPO AP 96678
SPE2DP-26-T-4823
SECTION B
PR: 7018127534 PRLI: 0001 CONT’D
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R23181
SOMERSET LPD 25
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R231816238HM65
RDD: 777
PROJ: LP5 TP 3
SUPP ADD: YNHM01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 09
DIC: A4A DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:09/03/2026
SPE2DP-26-T-4823 NSN/Part Number: 6505-01-194-7265 Quantity: 1 PG Purchase Request: 7018127534QTY: 1 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS